Latka logo

2024 Revenue

$5.4M(Est.)

Team

33

Founded

2015

Biologix Revenue (2024)

Biologix generated an estimated $5.4M in annual revenue in 2024. Source: GetLatka estimate

Obstructive sleep apnea SaaS platform

Last updated

Biologix Revenue

In 2024, Biologix's revenue reached $5.4M. The company previously reported $3.8M in 2023. Since its launch in 2015, Biologix has shown consistent revenue growth.

Biologix Revenue GrowthReported revenue / ARR over time · latest figure estimated$0$1.3M$2.5M$3.8M$5M$6.3M201520172019202120232024$0$2.7M$3.8M$5.4MSource: GetLatka.com
YearMilestoneSource
2024Biologix Hit $5.4m revenue in October 2024Estimated
2023Biologix Hit $3.8m revenue in December 2023Estimated
2021Biologix Hit $2.7m revenue in April 2021Not recorded
2015Launched with $0 revenue

Founder / CEO

Tacito Almeida

CEO

Tacito Almeida is the Founder & CEO at Biologix.

Biologix Employees & Team Size

Biologix employs approximately 33 people as of 2026, up from 21 in 2023.

Biologix Team GrowthReported headcount over time0815233038201520172019202120232024003333Source: GetLatka.com
YearMilestoneSource
2024Reached 33 employees (December 2024)Not recorded
2024Reached 35 employees (October 2024)Not recorded
2023Reached 21 employees (December 2023)Not recorded
2022Reached 21 employees (December 2022)Not recorded
2021Reached 18 employees (December 2021)Not recorded
2021Reached 32 employees (April 2021)Not recorded

Frequently Asked Questions about Biologix

What is Biologix's revenue?

As of 2024, Biologix generated an estimated $5.4M in annual revenue.

Who founded Biologix?

Biologix was founded by Tacito Almeida.

When was Biologix founded?

Biologix was founded in 2015.

Who is the CEO of Biologix?

The CEO of Biologix is Tacito Almeida.

How many employees does Biologix have?

As of 2024, Biologix had 33 employees.

Where is Biologix headquartered?

Biologix is headquartered in São Paulo, Sao Paulo, Brazil.

Data and Sources

All figures on this page are taken directly from interviews or are estimates from public sources and proprietary models. Not financial advice. Read full disclaimer.

Claim this profile